A case of metastatic carcinoma of anal fistula caused by implantation from rectal cancer by unknown
CASE REPORT Open Access
A case of metastatic carcinoma of anal
fistula caused by implantation from rectal
cancer
Rina Takahashi1*, Ryosuke Ichikawa1, Singo Ito1, Kosuke Mizukoshi1, Shun Ishiyama1, Kiichi Sgimoto1,
Yutaka Kojima1, Michitoshi Goto1, Yuichi Tomiki1, Takashi Yao2 and Kazuhiro Sakamoto1
Abstract
This case involved an 80-year-old man who was seen for melena. Further testing revealed a tubular
adenocarcinoma 50 mm in size in the rectum. In addition, an anal fistula was noted behind the anus along with
induration. A biopsy of tissue from the external (secondary) opening of the fistula also revealed adenocarcinoma.
Nodules suspected of being metastases were noted in both lung fields. The patient was diagnosed with rectal
cancer, a cancer arising from an anal fistula, and a metastatic pulmonary tumor, and neoadjuvant chemotherapy
was begun. A laparoscopic abdominoperineal resection was performed 34 days after 6 cycles of mFOLFOX-6
therapy. Based on pathology, the rectal cancer was diagnosed as moderately differentiated adenocarcinoma, and
this adenocarcinoma had lymph node metastasis (yp T3N2aM1b). There was no communication between the rectal
lesion and the anal fistula, and a moderately differentiated tubular adenocarcinoma resembling the rectal lesion
was noted in the anal fistula. Immunohistochemical staining indicated that both the rectal lesion and anal fistula
were cytokeratin 7 (CK7) (−) and cytokeratin 20 (CK20) (+), and the patient’s condition was diagnosed as
implantation of rectal cancer in an anal fistula.
In instances where an anal fistula develops in colon cancer, cancer implantation in that fistula must also be taken
into account, and further testing should be performed prior to surgery.
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Background
A handful of studies have reported primary cancer aris-
ing from a chronic anal fistula [1], but implantation of
tumor cells in an anal fistula is rare. Only 27 cases of
this condition have been reported since the report by
Guiss et al. [2]. As reported here, the current authors
encountered a case in which cancer cells migrating from
rectal cancer were implanted in an anal fistula.
Case presentation
This case involved an 80-year-old man. At age 76, a
stent had been placed in the man’s left coronary artery
to treat coronary arteriosclerosis. As of August 2013, the
man was seen by his previous physician for melena.
Colonoscopy revealed rectal cancer, and the patient was
referred to our hospital for further testing and
treatment.
Upon examination, a mass was not palpated during a
rectal examination, but the external opening of an anal
fistula was noted behind the anus (Fig. 1a). The fistula
was straight and could be palpated induration. There
was granulation tissue at the external opening, but the
patient had no subjective symptoms like pain or dis-
charge of pus, and the timing when the anal fistula de-
veloped was unclear.
Blood chemistry results revealed anemia with Hb of
10.0 g/dl. The level of the tumor marker CEA was elevated
(26.9 ng/ml).
Colonoscopy revealed the lower margins of a tumor in
the rectum 7 cm from the anal verge. This lesion was
50 mm in size and covered two-thirds of the circumfer-
ence of the rectum (Fig. 2a). Based on a biopsy, the
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tumor was diagnosed as well-differentiated tubular
adenocarcinoma (Fig. 3a). In addition, the fistula was
also diagnosed as adenocarcinoma based on a biopsy
(Fig. 3b).
A CT scan revealed thickening of the rectal wall with
contrast enhancement and swelling of the mesorectum.
The scan also revealed five nodules of 12 mm in size in
both lungs that were suspected of being metastases.
Thus, the patient’s condition was diagnosed as rectal
cancer, a cancer arising from an anal fistula, and a meta-
static pulmonary tumor, and neoadjuvant chemotherapy
(NAC) was initiated with 6 cycles of mFOLFOX-6 ther-
apy. The patient received oxaliplatin 75 mg/m2, 5-
fluorouracil (320 mg/m2 by bolus infusion and 2000 mg/
m2 by continuous infusion), and leucovorin 200 mg/m2.
After NAC, the level of the tumor marker CEA
dropped to 4.6 ng/ml. Colonoscopy revealed a tumor
covering one-fourth of the circumference of the rectum
7 cm from the anal verge. Ulcerated folds were less
prominent (Fig. 2b). The tumor was diagnosed as well-
differentiated tubular adenocarcinoma based on a bi-
opsy. The second external opening of an anal fistula
behind the anus was no longer evident (Fig. 1b).
After NAC, a CT scan revealed reduced thickening of
the rectal wall and shrinkage of mesorectum lymph
nodes. Nodules in both lung fields shrank, and tumor
shrinkage according to the RECIST criteria was 34 %.
Adverse events due to chemotherapy were not noted,
and a laparoscopic abdominoperineal resection was per-
formed 34 days after the final cycle of chemotherapy.
During perineal resection, adequate margins were ob-
tained around the anal fistula and the rectum was dis-
sected while palpating the fistula. Part of the levator ani
near the fistula was laparoscopically resected, but efforts
were made to preserve as much of the levator ani as
possible on the opposite side of the anal fistula. The end
stoma was created through the extraperitoneal route.
The anal fistula was a simple fistula.
Histopathology indicated that the rectal lesion was a
moderately differentiated adenocarcinoma, and the
adenocarcinoma had lymph node metastasis (yp
T3N2aM1b, yp stage IV B). The pathological response
about effective of NAC was grade 1b (Japanese Classifi-
cation of the Colorectal Carcinoma, Seventh Edition) [3].
The length of anal fistula was 15 mm; the internal
opening was found at the behind anal crypts. The anal
a b
Fig. 1 a The second external opening of an anal fistula was noted behind the anus. b After NAC, the second external opening of an anal fistula
behind the anus was no longer evident
ba
Fig. 2 a Colonoscopy revealed the lower margins of a tumor in the rectum 7 cm from the anal verge. b Colonoscopy after NAC. Ulcerated folds
were less prominent
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fistula was found to be a moderately differentiated tubu-
lar adenocarcinoma resembling the rectal lesion, but
communication with the rectal lesion was not noted
(Fig. 4). In immunohistochemical staining, both the rec-
tal lesion and the anal fistula stained negative (−) with
antibodies to cytokeratin 7 (CK7) and positive (+) with
antibodies to cytokeratin 20 (CK20) (Fig. 5).
The patient’s postoperative course was satisfactory,
and the patient was discharged on day 14 of
hospitalization. As of 14 months postoperatively, the
patient continues to receive chemotherapy on an out-
patient basis. New metastases have not been noted, and
there has been no change in the lung metastases and pa-
tient’s status.
Discussion
A persistent anal fistula with recurrent inflammation is
known to lead to primary cancer, and such cancer de-
velops in 0.1 % of all anal fistulae [4]. As Skir [5] and
Mclntyre et al. [6] noted, the diagnostic criteria for
ba
Fig. 3 a Histopathology indicated that the rectal lesion was a moderately differentiated adenocarcinoma (H&E ×40). b Histopathology indicated
that the anal fistula was found to be a moderately differentiated tubular adenocarcinoma (H&E ×40)
a
b c
Fig. 4 a There is no communication with rectal lesion and the anal fistula b Histopathology indicated that the rectal lesion was a moderately
differentiated adenocarcinoma (H&E ×20). c The anal fistula was found to be a moderately differentiated tubular adenocarcinoma resembling the
rectal lesion (H&E ×20)
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primary cancer arising from an anal fistula are as fol-
lows: (1) recurring inflammation of the fistula for at least
10 years, (2) increasing pain and induration at the fis-
tula, (3) mucus secretion, (4) no primary cancer at the
rectum and anus, and (5) the fistula has an opening in
the anal canal or an anal crypt.
That said, cancer implantation in an anal fistula occurs
when cancer cells migrating from advanced colon cancer
are implanted in an anal fistula. The basis for this diag-
nosis is when implanted cells have the same histologic
type as the primary tumor. In addition, immunohistol-
ogy can provide clues to differentiate cancer implant-
ation in an anal fistula from other types of cancer. A
combination of CK7 and CK20 can facilitate this deter-
mination. Loy et al. [7] reported that the vast majority of
colon cancers (80 %) are CK7 (−)/CK20 (+) while some
(16 %) are CK7 (+)/CK20 (+) and a few (4 %) are CK7
(−)/CK20 (−). In six of seven cases of primary cancer
arising from an anal fistula, those cancers were CK7
(+)/CK20 (−) [8]. In instances where colon cancer and
cancer arising from an anal fistula are both present, the
primary cancer must be differentiated from metastases.
In cases previously encountered by the current authors,
this cancer had a histologic type resembling colon can-
cer, and immunohistochemical staining indicated that
both the lesion and the fistula stained negative for CK7
and positive for CK20. Thus, a diagnosis of implantation
of colon cancer in an anal fistula was made.
According to Umpleby et al. [9], colon cancer cells
shed into the intestinal lumen are implanted in injured
mucosa. An inflammatory response to a stimulus (like a
bacterial infection) or wound healing activates cancer
cell growth, presumably resulting in cancer implantation
in an anal fistula [10, 11].
Cancer implantation in an anal fistula was first re-
ported by Guiss et al. [2], though similar implantation of
colorectal cancer cells in a hemorrhoidectomy wound
[12] and implantation of rectal cancer in the anal canal
due to anal injury occurring during insertion of a circu-
lar stapler [13] have also been reported. Thus, the poten-
tial for cancer implantation must also be taken into
account in patients with colon cancer who develop an
anal fistula and in patients who have undergone surgery
for an anal disorder. Such patients must be carefully
followed prior to surgery. When the anus is handled
during surgery, avoiding and preventing injury to the
anoderm is crucial. When cancer arising from an anal
fistula is diagnosed, the proximal intestine should be ex-
amined with metastasis of colon cancer in mind.
There are 27 reported cases of implantation of colon can-
cer in an anal fistula, which include cases previously en-
countered by the current authors [14–16]. In most of those
cases, the primary tumor was found in the sigmoid colon
or the rectum (2 in the descending colon, 13 in the sigmoid
colon, 10 in the upper rectum, and 2 in the lower rectum).
In about half of the 27 cases, cancer arising from an anal
fistula was diagnosed prior to resection of the primary
tumor, and an abdominoperineal resection was performed.
A handful of reports have described performing only local
resection when cancer arising from an anal fistula was diag-
nosed after resection of the primary tumor [17, 18]. Regard-
less, there are no reports of local recurrence after surgery.
ba
dc
Fig. 5 Immunohistochemical staining (×20). Rectum lesion stained CK7 (−) (a) CK20 (+) (b) and the fistula stained CK7 (−) (c) and CK20 (+) (d)
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In the event of cancer implantation in an anal fistula, the
cancer must be resected with adequate margins.
In this case, a large tumor was noted along with im-
plantation of colorectal cancer in an anal fistula, so pre-
operative chemotherapy was performed. The tumor
shrank as a result, and the tumor was completely re-
moved. The fistula was also removed, albeit to a limited
extent. In addition, implantation of cancer cells and pul-
monary metastases were noted, so systemic treatment was
provided in the form of preoperative chemotherapy. The
tumor responded well to chemotherapy, and chemother-
apy was continued postoperatively. As a result, SD has
been maintained. Thus, the treatment chosen was
appropriate.
Conclusions
The current authors encountered a case in which cancer
arising from an anal fistula was diagnosed based on a bi-
opsy prior to surgery. In that case, cancer implantation in
that fistula was similarly diagnosed based on immunostain-
ing after surgery. In instances where an anal fistula develops
in colon cancer, cancer implantation in that fistula must
also be taken into account, and further testing should be
performed prior to surgery.
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